이뮨온시아

424870KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

3,090KRWMarket close of 10/21 (Wed)

Up +1.15%+35KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)2,940KRWDown -4.85%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
3,090
High
3,170
Low
3,060
Day range
Day range low 3,060 high 3,170, open 3,090, close 3,090, previous close 3,055
Volume
20×10K shares
618.55 million KRW 0.18× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 2,445 to 15,380 won, 5% up from the low

5% of the way up from the lowest close in 1 year (252 sessions) · -79.9% from the high

Usual range

Nothing unusual in the 5 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Daily moveusual range+1.15%+1.15%, 0.4× the usual (20-session average ±3.03%)
    That day +1.15% · usual ±3.03% · large-move threshold ±6.1%
  • Trading valueusual range0.2×618.55 million KRW, 0.2× the 20-session average
    0.18× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+700.00 million KRWusual range
  • Data date10/21 (Wed)Market close
See the full check report

Same sector · 바이오 R&D

Up +3.03%

· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -5.5%Up +3.90%60.7B KRW
올릭스Close over the last 20 sessions -6.4%Up +9.53%26.1B KRW
디앤디파마텍Close over the last 20 sessions -6.0%Up +6.65%22.0B KRW
리가켐바이오Close over the last 20 sessions -14.3%Up +2.00%12.9B KRW
프로티나Close over the last 20 sessions +35.7%Up +7.23%11.0B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.